These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 29116379

  • 1. Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer.
    Murakami S, Saito H, Kondo T, Ito H, Oshita F, Yamada K.
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):81-87. PubMed ID: 29116379
    [Abstract] [Full Text] [Related]

  • 2. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
    Shukuya T, Yamanaka T, Seto T, Daga H, Goto K, Saka H, Sugawara S, Takahashi T, Yokota S, Kaneda H, Kawaguchi T, Nagase S, Oguri T, Iwamoto Y, Nishimura T, Hattori Y, Nakagawa K, Nakanishi Y, Yamamoto N, West Japan Oncology Group.
    Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
    [Abstract] [Full Text] [Related]

  • 3. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.
    Oshita F, Yamada K, Kato Y, Ikehara M, Noda K, Tanaka G, Nomura I, Suzuki R, Saito H.
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):73-8. PubMed ID: 12750839
    [Abstract] [Full Text] [Related]

  • 4. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhang P, Feng FY, Wu LY, Hu Y, Liu JW, Gao YJ, Guan XQ, Nan KJ, Suo AL, Wang XW, Zhang MH, Zhang WD, Li CW, Zhang Y, Zhao JB.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
    [Abstract] [Full Text] [Related]

  • 5. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
    Mori T, Makino H, Okubo T, Fujiwara Y, Sawada M, Kuroboshi H, Tsubamoto H, Murakoshi H, Motohashi T, Kitawaki J, Ito K.
    J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II and III non-small cell lung cancer.
    Sonobe M, Okubo K, Teramukai S, Yanagihara K, Sato M, Sato T, Chen F, Sato K, Fujinaga T, Shoji T, Omasa M, Sakai H, Miyahara R, Bando T, Date H.
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1199-206. PubMed ID: 25253046
    [Abstract] [Full Text] [Related]

  • 7. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
    Kenmotsu H, Niho S, Ito T, Ishikawa Y, Noguchi M, Tada H, Sekine I, Watanabe S, Yoshimura M, Yamamoto N, Oshita F, Kubota K, Nagai K.
    Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
    [Abstract] [Full Text] [Related]

  • 8. A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer.
    Schmid-Bindert G, Engel-Riedel W, Reck M, Schuette W, Stöhlmacher J, Fischer JR, Mazières J, Chouaid C, Wolf M, Vinolas N, Soldatenkova V, Ripoche V, Nguyen T, Visseren-Grul C.
    Lung Cancer; 2015 Dec; 90(3):397-404. PubMed ID: 26791798
    [Abstract] [Full Text] [Related]

  • 9. A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer.
    Teramoto K, Asada Y, Ozaki Y, Suzumura Y, Nakano Y, Sawai S, Tezuka N, Inoue S, Fujino S.
    Cancer Chemother Pharmacol; 2012 Oct; 70(4):531-7. PubMed ID: 22864949
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of nedaplatin and irinotecan followed by gefitinib for elderly patients with unresectable non-small cell lung cancer.
    Oshita F, Yamada K, Saito H, Noda K.
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):465-70. PubMed ID: 17960380
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.
    Miyamoto M, Takano M, Kuwahara M, Soyama H, Kato K, Matuura H, Sakamoto T, Takasaki K, Aoyama T, Yoshikawa T, Furuya K.
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):111-117. PubMed ID: 29124328
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer.
    Oshita F, Ohe M, Honda T, Murakami S, Kondo T, Saito H, Noda K, Yamashita K, Nakayama Y, Yamada K.
    Br J Cancer; 2010 Oct 26; 103(9):1325-30. PubMed ID: 20940720
    [Abstract] [Full Text] [Related]

  • 13. Nedaplatin and irinotecan with concurrent thoracic radiotherapy followed by docetaxel consolidation in patients with locally advanced non-small cell lung cancer.
    Oshita F, Murakami S, Kondo T, Saito H, Yamada K, Nakayama Y.
    J Exp Ther Oncol; 2017 May 26; 12(1):17-23. PubMed ID: 28472560
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706.
    Takeda K, Negoro S, Tanaka M, Fukuda H, Nakagawa K, Kawahara M, Semba H, Kudoh S, Sawa T, Saijo N, Fukuoka M.
    Jpn J Clin Oncol; 2011 Jan 26; 41(1):25-31. PubMed ID: 20802006
    [Abstract] [Full Text] [Related]

  • 15. Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung.
    Kenmotsu Y, Oshita F, Sugiura M, Murakami S, Kondo T, Saito H, Yamada K.
    Anticancer Res; 2012 Apr 26; 32(4):1453-6. PubMed ID: 22493385
    [Abstract] [Full Text] [Related]

  • 16. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer.
    Yamashita Y, Kataoka K, Ishida T, Matsuura M, Seno N, Mukaida H, Miyahara E, Miyata Y, Okita R, Shimizu K, Watari M, Okumichi T, Okada M.
    J Thorac Oncol; 2008 Jun 26; 3(6):612-6. PubMed ID: 18520800
    [Abstract] [Full Text] [Related]

  • 17. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
    Shen WY, Ji J, Zuo YS, Pu J, Xu YM, Zong CD, Tao GZ, Chen XF, Ji FZ, Zhou XL, Han JH, Wang CS, Yi JG, Su XL, Zhu WG.
    Radiother Oncol; 2014 Jan 26; 110(1):120-5. PubMed ID: 24183868
    [Abstract] [Full Text] [Related]

  • 18. Nedaplatin or oxaliplatin combined with paclitaxel and docetaxel as first-line treatment for patients with advanced non-small cell lung cancer.
    Zhang K, Qin H, Pan F, Liu E, Liang H, Ruan Z.
    Med Sci Monit; 2014 Dec 30; 20():2830-6. PubMed ID: 25548985
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM, Herndon JE, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR.
    J Clin Oncol; 2008 Nov 01; 26(31):5043-51. PubMed ID: 18809614
    [Abstract] [Full Text] [Related]

  • 20. A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer.
    Okamoto T, Yano T, Shimokawa M, Takeo S, Yamazaki K, Sugio K, Takenoyama M, Nagashima A, Tsukamoto S, Hamatake M, Yokoyama H, Ueda H, Motohiro A, Tagawa T, Shoji F, Kometani T, Saito G, Fukuyama Y, Toyokawa G, Osoegawa A, Emi Y, Maehara Y, Kyushu University Lung Surgery Study Group (KLSS) Japan.
    Lung Cancer; 2018 Oct 01; 124():255-259. PubMed ID: 30268470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.